Because so much about these conditions remains a mystery, conventional medicine often has a pessimistic perspective regarding treatment and prognosis. Our functional approach has produced exceptional results for patients with these challenging conditions.
After the acute phase of a stroke or a neurological diagnosis, patients are frequently told that what remains is what they keep. Rehabilitation is offered; biological recovery generally is not.
That framing underestimates neuroplasticity — the brain's capacity to reorganize and recover function given the right conditions.
Dr. Kellman targets the conditions neuroplasticity requires: reduced neuroinflammation, adequate cellular energy, restored microbiome signaling, and sufficient nutrient and hormonal support.
Treatment may combine IV therapies, peptides, targeted nutrients, and technologies including NovoTHOR whole-body red light, PEMF, and the Magnesphere to support recovery and autonomic balance.
Neuroplasticity persists well beyond the standard rehabilitation window. Dr. Kellman works with patients months and years out, focusing on the biological conditions that allow the brain to continue reorganizing.
NovoTHOR whole-body red light therapy, PEMF, and the Magnesphere immersion system, selected based on the individual presentation and used alongside nutritional and IV protocols.